EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination

Nouhaila Najimi, Chaimae Kadi, Noureddine Elmtili, Fouad Seghrouchni, Youssef Bakri

Human Antibodies · 2024

DOI: 10.3233/hab-230017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Antibodies, 2024. Verfasst von Nouhaila Najimi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Pathologies Biology and Center of Genomic of Human Pathologies Biology, Faculty of Sciences, Mohammed V University, Rabat, Morocc…. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Immunity, Humoral, Antibodies, Viral. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 115 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Following infection and vaccination against SARS-CoV-2, humoral components of the adaptive immune system play a key role in protecting the host. Specifically, B cells generate high-affinity antibodies against various antigens of the virus. In this review, we discuss the mechanisms of immunity initiation through both natural infection and vaccination, shedding light on the activation of B cell subsets in response to SARS-CoV-2 infection and vaccination. The innate immune system serves as the initial line of primary and nonspecific defence against viruses. However, within several days following infection or a vaccine dose, a virus-specific immune response is initiated, primarily by B cells that produce antibodies. These antibodies contribute to the resolution of the disease. Subsequently, these B cells transition into memory B cells, which play a crucial role in providing long-term immunity against the virus. CD4+ T helper cells initiate a cascade, leading to B cell somatic hypermutation, germinal center memory B cells, and the production of neutralizing antibodies. B-cell dysfunction can worsen disease severity and reduce vaccine efficacy. Notably, individuals with B cell immunodeficiency show lower IL-6 production. Furthermore, this review delves into several aspects of immune responses, such as hybrid immunity, which has shown promise in boosting broad-spectrum protection. Cross-reactive immunity is under scrutiny as well, as pre-existing antibodies can offer protection against the disease. We also decipher breakthrough infection mechanisms, especially with the novel variants of the virus. Finally, we discuss some potential therapeutic solutions regarding B cells including convalescent plasma therapy, B-1 cells, B regulatory cell (Breg) modulation, and the use of neutralizing monoclonal antibodies in combating the infection. Ongoing research is crucial to grasp population immunity trends and assess the potential need for booster doses in maintaining effective immune responses against potential viral threats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Immunity, HumoralAntibodies, ViralCOVID-19 VaccinesAntibodies, NeutralizingVaccinationB-LymphocytesHumansMemory B CellsImmunity, Innate

Stichwörter der Autor:innen

B LymphocytesB cells subsetsCOVID-19 InfectionHumoral immunityHybrid ImmunitySARS-CoV-2breakthrough infectionscross-reactive immunityhigh affinity antibodiestherapeutic approachesvaccination responses

Substanzen

Antibodies, ViralCOVID-19 VaccinesAntibodies, Neutralizing

Autor:innen und Institutionen

  • Laboratory of Human Pathologies Biology and Center of Genomic of Human Pathologies Biology, Faculty of Sciences, Mohammed V University, Rabat, Morocco.
  • Mohammed VI Center for Research and Innovation, Rabat, Morocco.
  • Mohammed VI University of Sciences and Health, Casablanca, Morocco.
  • Laboratory of Biology and Health, Faculty of Sciences of Tétouan, Abdelmalek Essaâdi University, Tétouan, Morocco.

Zitieren

APA

Najimi, N., Kadi, C., Elmtili, N., Seghrouchni, F., & Bakri, Y. (2024). Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination. Human Antibodies. https://doi.org/10.3233/hab-230017

Vancouver

Najimi N, Kadi C, Elmtili N, Seghrouchni F, Bakri Y. Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination. Human Antibodies. 2024. doi:10.3233/hab-230017

BibTeX
@article{Najimi2024,
  author = {Najimi, Nouhaila and Kadi, Chaimae and Elmtili, Noureddine and Seghrouchni, Fouad and Bakri, Youssef},
  title = {Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination},
  journal = {Human Antibodies},
  year = {2024},
  doi = {10.3233/hab-230017}
}
Kostenlos starten →